Australia markets closed

Xenon Pharmaceuticals Inc. (XENE)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
39.50-1.59 (-3.87%)
At close: 04:00PM EDT
39.50 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts16161717
Avg. Estimate-0.66-0.7-2.91-3.29
Low estimate-0.77-0.82-3.54-4.47
High estimate-0.56-0.58-2.35-1.11
Year ago EPS-0.63-0.72-2.73-2.91
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts15151717
Avg. EstimateN/AN/A2.39M5.64M
Low estimateN/AN/AN/AN/A
High estimateN/AN/A25M70.22M
Year ago salesN/AN/AN/A2.39M
Sales growth (year/est)N/AN/AN/A136.00%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.62-0.7-0.77-0.76
Actual EPS-0.63-0.72-0.73-0.64
Difference-0.01-0.020.040.12
Surprise %-1.60%-2.90%5.20%15.80%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.66-0.7-2.91-3.29
7 days ago-0.66-0.7-2.91-3.29
30 days ago-0.66-0.7-2.91-3.28
60 days ago-0.76-0.79-3.28-3.68
90 days ago-0.76-0.79-3.28-3.68
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesXENEIndustrySector(s)S&P 500
Current qtr.-4.80%N/AN/AN/A
Next qtr.2.80%N/AN/AN/A
Current year-6.60%N/AN/AN/A
Next year-13.10%N/AN/AN/A
Next 5 years (per annum)8.90%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A